Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Making patient safety the centerpiece of medical liability reform

Article Abstract:

The medical liability climate and patient safety can be improved by reducing the rates of preventable patient injuries, promoting open communication between physicians and patients, ensuring patients access to fair compensation for legitimate medical injuries and reducing liability insurance premiums for health care providers. The main provisions of the National medical Error Disclosure and Compensation (MEDiC) Bill (S 1784), which is introduced to overcome the impasse in the debate on medical liability, are described.

Author: Clinton, Hillary Rodham, Obama, Barack
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
General services, Medical Service and Health Insurance, Safety and security measures, Health care industry, Health insurance industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Institute of medicine on drug safety

Article Abstract:

The US drug-safety system is assessed by the Institute of Medicine (IOM), on the request of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). It identified a lack of clear regulatory authority, chronic underfunding, organizational difficulties and a scarcity of post-approval data and recommends focus of an ongoing effort to acquire, integrate and communicate information that will allow physicians and patients to use drugs wisely and well.

Author: Psaty, Bruce M., Burke, Sheila P.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
All Other Miscellaneous Ambulatory Health Care Services, Disease Testing Programs, Drugs, Drug evaluation, Drug approval

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Safety of long-acting beta-agonists - An urgent need to clear the air

Article Abstract:

The Food and Drug Administration (FDA) in July 2005 has issued a stern public health advisory alerting health care professionals and patients that the long-acting beta-agonist, salmeterol might increase the chance of severe asthma episodes, and death when those episodes occur. The drug failed in patients with severe disease to control asthma symptoms fully, necessitating additional treatment with inhaled bronchodilators.

Author: Martinez, Fernando D.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
Complications and side effects, Risk factors, Asthma, Salmeterol, Public health advisory groups

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Government regulation, United States. Food and Drug Administration
Similar abstracts:
  • Abstracts: Accounting for time: Insights from a life-table analysis of the efficacy of medical abortion. The role of emergency contraception
  • Abstracts: Perceptions of the role of the hospital palliative care team. Trust debts put PFI plans in crisis
  • Abstracts: The student experience. Prioritising to safeguard the integrity of nurse education. Is student poverty jeopardising the future of nursing?
  • Abstracts: Is it unethical to offer incentives for patient referrals? Ethical moment. Ethical moment: how can I handle a rude patient?
  • Abstracts: Effect of vitamin E and beta carotene on the incidence of angina pectoris: a randomized, double-blind, controlled trial
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.